Optimization of image-guided targeting in renal focal therapy

Raymond J. Leveillee, Rajan Ramanathan

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Focal renal therapy for small renal masses (T1a or T 1b) has been used as primary treatment for patients with comorbidities who are considered poor candidates for surgical resection. With a continuing effort toward optimization of minimally invasive nephron-sparing modalities, the effort to expand the patient pool will continue. As long-term results of renal ablative therapies become available and the safety, precision, and efficacy become well established, renal ablation may be used with increasing frequency for a wider group of patients. When this happens, high-quality imaging for localization and targeting of these renal lesions will become the central core of the treatment, with emphasis on superior results, accurate positioning of the probe, precise localization of the tumor, and real-time intraoperative monitoring of outcomes.

Original languageEnglish
Pages (from-to)729-744
Number of pages16
JournalJournal of Endourology
Volume24
Issue number5
DOIs
StatePublished - May 1 2010
Externally publishedYes

Fingerprint

Kidney
Intraoperative Monitoring
Therapeutics
Nephrons
Comorbidity
Safety
Neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Optimization of image-guided targeting in renal focal therapy. / Leveillee, Raymond J.; Ramanathan, Rajan.

In: Journal of Endourology, Vol. 24, No. 5, 01.05.2010, p. 729-744.

Research output: Contribution to journalArticle

Leveillee, Raymond J. ; Ramanathan, Rajan. / Optimization of image-guided targeting in renal focal therapy. In: Journal of Endourology. 2010 ; Vol. 24, No. 5. pp. 729-744.
@article{d6d94396537b46b1a56c8de332c4e919,
title = "Optimization of image-guided targeting in renal focal therapy",
abstract = "Focal renal therapy for small renal masses (T1a or T 1b) has been used as primary treatment for patients with comorbidities who are considered poor candidates for surgical resection. With a continuing effort toward optimization of minimally invasive nephron-sparing modalities, the effort to expand the patient pool will continue. As long-term results of renal ablative therapies become available and the safety, precision, and efficacy become well established, renal ablation may be used with increasing frequency for a wider group of patients. When this happens, high-quality imaging for localization and targeting of these renal lesions will become the central core of the treatment, with emphasis on superior results, accurate positioning of the probe, precise localization of the tumor, and real-time intraoperative monitoring of outcomes.",
author = "Leveillee, {Raymond J.} and Rajan Ramanathan",
year = "2010",
month = "5",
day = "1",
doi = "10.1089/end.2009.0622",
language = "English",
volume = "24",
pages = "729--744",
journal = "Journal of Endourology",
issn = "0892-7790",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Optimization of image-guided targeting in renal focal therapy

AU - Leveillee, Raymond J.

AU - Ramanathan, Rajan

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Focal renal therapy for small renal masses (T1a or T 1b) has been used as primary treatment for patients with comorbidities who are considered poor candidates for surgical resection. With a continuing effort toward optimization of minimally invasive nephron-sparing modalities, the effort to expand the patient pool will continue. As long-term results of renal ablative therapies become available and the safety, precision, and efficacy become well established, renal ablation may be used with increasing frequency for a wider group of patients. When this happens, high-quality imaging for localization and targeting of these renal lesions will become the central core of the treatment, with emphasis on superior results, accurate positioning of the probe, precise localization of the tumor, and real-time intraoperative monitoring of outcomes.

AB - Focal renal therapy for small renal masses (T1a or T 1b) has been used as primary treatment for patients with comorbidities who are considered poor candidates for surgical resection. With a continuing effort toward optimization of minimally invasive nephron-sparing modalities, the effort to expand the patient pool will continue. As long-term results of renal ablative therapies become available and the safety, precision, and efficacy become well established, renal ablation may be used with increasing frequency for a wider group of patients. When this happens, high-quality imaging for localization and targeting of these renal lesions will become the central core of the treatment, with emphasis on superior results, accurate positioning of the probe, precise localization of the tumor, and real-time intraoperative monitoring of outcomes.

UR - http://www.scopus.com/inward/record.url?scp=77952578902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952578902&partnerID=8YFLogxK

U2 - 10.1089/end.2009.0622

DO - 10.1089/end.2009.0622

M3 - Article

C2 - 20477541

AN - SCOPUS:77952578902

VL - 24

SP - 729

EP - 744

JO - Journal of Endourology

JF - Journal of Endourology

SN - 0892-7790

IS - 5

ER -